Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 16
Clinical Trial Report
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 1,535 | Dovepress* | 1,418+ | 41 | 1,459 | |
| PubMed Central* | 117 | 21 | 138 | ||
| Totals | 1,535 | 62 | 1,597 | ||
| *Since 12 April 2024 | |||||
View citations on PubMed Central and Google Scholar